免疫细胞在瘤微环境中的代谢途径的细胞因子介导调节
Alireza Soleimani Mamalo1, Mohammadreza Pashaei2, Mohammad Valilo3
1Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
Naunyn-Schmiedeberg's archives of pharmacology
|April 12, 2025
概括
细胞因子在瘤微环境 (TME) 中重编程免疫细胞代谢,影响癌症生长和治疗耐药性. 针对这些细胞因子介导的代谢途径,就像涉及Interleukin-15的途径一样,提供了新的免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 代谢生物学代谢生物学
背景情况:
- 癌症是全球主要的死亡原因,其特点是不受控制的细胞生长.
- 瘤微环境 (TME) 极大地影响癌症的进展,治疗反应和免疫系统调节.
- 在TME内的免疫细胞表现出双重作用,要么抑制或促进基于代谢和细胞因子线索的瘤生长.
研究的目的:
- 审查细胞因子介导的代谢重编程在TME内的免疫细胞功能中的作用.
- 探索如何改变新陈代谢和细胞因子信号影响癌症免疫反应.
- 在这些途径中确定增强癌症免疫治疗的潜在治疗点.
主要方法:
- 文献综述侧重于TME中的细胞因子信号传递和代谢重编程.
- 分析由代谢变化影响的免疫细胞功能的分析.
- 检查特定的细胞因子 (例如IL-15,IL-10,IL-4) 和它们对免疫细胞代谢的影响.
主要成果:
- 细胞因子显著调节免疫细胞的新陈代谢,从而改变它们的抗瘤或促瘤活动.
- 在TME内的代谢重编程可以导致免疫抑制或激活.
- 特定的互白蛋白 (IL-15,IL-10,IL-4) 在调节免疫细胞代谢以获得治疗益处方面显示出潜力.
结论:
- 细胞因子驱动的代谢重编程是TME内的免疫细胞行为的关键因素.
- 准代谢途径和细胞因子信号传递为新型癌症免疫疗法提供了一个有希望的途径.
- 了解这些相互作用可以克服免疫抵抗并提高治疗效率.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Tumor Immunotherapy
406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406
Cytotoxic T Cells-mediated Immune Response
737
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
737
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K


